Stella Diagnostics, Inc. (SLDX)
0.01
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Stella Diagnostics Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 3.591M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 0.00 |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | |
| September 30, 2015 | 1.632M |
| June 30, 2015 | 0.0026M |
| March 31, 2015 | -0.0006M |
| December 31, 2014 | 0.0002M |
| September 30, 2014 | -0.001M |
| June 30, 2014 | 0.0025M |
| March 31, 2014 | -0.0116M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | 0.00 |
| DataMeds AI, Inc. | -0.2421M |
| Interpace Biosciences, Inc. | -0.057M |
| Medical Marijuana, Inc. | 0.0026M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.9776M |
| Cash from Financing (Quarterly) | 0.9533M |
| Free Cash Flow | -2.365M |
| Free Cash Flow Per Share (Quarterly) | -0.0032 |
| Free Cash Flow to Equity (Quarterly) | -11.10M |
| Free Cash Flow to Firm (Quarterly) | -0.8891M |
| Free Cash Flow Yield | -75.62% |